Evidence suggests that amyloid β protein (Aβ) accumulation and neuronal degeneration (elevated tau/phosphorylated tau) are two major biomarkers of AD, and also the core neuropathological elements of the disease [11]. Here, MAPT is linked to Alzheimer disease.